Family-based diabetes education program in the Marshall Islands
Official title: Family Model Diabetes Self-Management Education in Faith-Based Organizations in the Republic of the Marshall Islands
Run by University of Arkansas · NCT05502016 · Data updated 2026-11-12
This study is testing a family-focused diabetes education program in the Marshall Islands to see if it helps people with type 2 diabetes and their families manage the condition better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 288 (estimated) |
| Sponsor | University of Arkansas Academic / other |
| Locations | 1 site (Springdale, Arkansas) |
| Status | Recruiting |
| Started | June 30, 2023 |
| Main results expected | January 31, 2027 |
| Study ends | January 31, 2027 |
| Registry record updated | December 8, 2025 |
| Trial ID | NCT05502016 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are self-reported Marshallese individuals aged 18 and older who have type 2 diabetes and at least one family member willing to participate.
✕Probably not a fit
Patients who have received diabetes self-management education in the past five years or have conditions that hinder their ability to follow the protocol may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of a family model diabetes self-management education and support program delivered in faith-based organizations in the Republic of the Marshall Islands. It involves a cluster-randomized controlled trial with a wait-list control group, targeting individuals with type 2 diabetes and their family members. The program is facilitated by trained community health workers and aims to improve diabetes management among participants. The study will include up to 288 participants with type 2 diabetes and their family members, focusing on culturally relevant education and support.
Why it matters
Potential benefit: If successful, this program could significantly improve diabetes management and health outcomes for individuals and families affected by type 2 diabetes in the Marshall Islands.
How similar studies have gone: While there is limited information on similar studies specifically in the Marshall Islands, family-based interventions for diabetes management have shown promise in other populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * self-reported Marshallese * 18 years of age or older * have type 2 diabetes (defined as having HbA1c equal to or greater than 6.5%) * have at least one family member willing to take part in the study Exclusion Criteria: * has received diabetes self-management education in the past five years * has a condition that makes it unlikely that the participant will be able to follow the protocol, such as terminal illness, non-ambulatory, severe mental illness, severely impaired vision or hearing, eating disorder * plans to move out of the geographic region
Where it's running
-
UAMS Institute for Community Health Innovation
Springdale, Arkansas, United States Recruiting
Study contacts
- Principal investigator: Pearl McElfish, PhD — University of Arkansas
- Study coordinator: Betsy O'Connor, MA
- Email: geoconnor@uams.edu
- Phone: 479-713-8000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Proliverenol for liver fat and insulin resistance in type 2 diabetes
This study tests whether adding Proliverenol to standard diabetes care can improve liver fat and blood sugar control in adults with type 2 diabetes.
-
Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.
-
Safety test of NNC9836-0001 in adults with overweight/obesity or type 2 diabetes
This study tests whether the new medicine NNC9836-0001 is safe and tolerable in adults who are overweight or have type 2 diabetes, compared to placebo.
-
RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes
This study tests the accuracy and safety of the RIGHTEST iFree 2 continuous glucose monitor in pregnant adults with type 1, type 2, or gestational diabetes.
-
EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes
This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.
-
Maridebart cafraglutide vs. semaglutide for type 2 diabetes on metformin
This trial tests whether maridebart cafraglutlide is as good as semaglutide at improving blood sugar in adults with type 2 diabetes who take metformin (with or without an SGLT-2 inhibitor).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.